The human gut represents one of the most diverse bacterial ecosystems. These 27 bacteria live in a mutualistic state with the host, however when this homeostatic balance 28 is perturbed due to an alteration in bacterial community composition and function 29 (dysbiosis), it can lead to disruption of normal host physiology. A role for gut microbiota 30 has been suggested in pathogenesis of colorectal cancer based on recent mice and human 31 studies. In a mouse model of colitis-associated colorectal cancer, Uronis et al. found that 32 risk for tumorigenesis was lower in germ-free conditions than with a conventional 33 microbiome (24). In another study Kostic et al. found 
Clostridium and Enterococcus spp (5). Although HFD-induced alteration in gut 51
microbiota are associated with colon cancer, it remains unclear how these alterations 52 promote colon cancer and if prevention of these changes can halt progression to colon 53
cancer. 54 55
There are several ways to target gut microbiota, one of which is a prebiotic 56 defined as "a non-digestible compound that through its metabolism by microorganisms in 57 the gut, modulates composition and/or activity of the gut microbiota thus conferring 58 beneficial physiological effects to the host" (4). Agarose, a major food ingredient in East 59
Asia obtained from seaweed, can be considered a prebiotic given its effect on gut 60 microbiota.
In the current study Higashimura et al. 
86
The authors in the current study also correlated changes in microbial composition 87 to changes in microbial function in order to identify potential mechanisms by which 88 AGO is protective. They found that lactic acid concentration was elevated in the ceacum 89 of HFD-fed mice that were supplemented with AGO consistent with an increase in 90
Lactobacillales. Succinic acid, a major by product of Bacteroides metabolism, was also 91 increased following HFD but suppressed by AGO supplementation. It is unclear if these 92 fermentative products directly influence colon tumorigenesis or are just reflective of 93 changes in community function as a result of AGO supplementation. 94
In the current study, AGO supplementation prevented the decrease in 96 cytoprotective ω-muricholic acid (MCA) and increased the ratio of MCA/ deoxycholic 97 acid (DCA), providing a potential mechanism for anti-tumorigenic effect of AGO. A 98 high physiologic level of a secondary bile acid, particularly deoxycholic acid (DCA), as 99 seen with HFD consumption (15), has been reported to be a risk factor for colon cancer in 100 humans (2, 3). DCA increases tyrosine phosphorylation of β-catenin, a member of the 101 cadherin family of transmembrane cell-cell adhesion receptors and a key component of 102 adherens junctions, which leads to enhanced colon cancer cell proliferation and 103 invasiveness (13). A recent study has also shown that DCA levels are significantly 104 higher in the sera of patients with colorectal adenomas (1), suggesting a link between 105 DCA and colon tumorigenesis (16, 19) . Since Clostridium sp. encode gene for 7 alpha 106 dehydroxylation enzymatic activity (7, 18), decreased Clostridium sp. levels seen with 107 AGO supplementation may in part be responsible for diminished DCA levels. Evidence supporting this hypothesis is observed in the current study where COX-1 117 expression is suppressed by AGO in HFD-fed mice. Besides HO-1, AGO might haveanti-tumorigenic effects by potentially reducing PA production in the intestine. PA's are 119 a regulator of epithelial cell division and high PA levels have been linked to 120 tumorigenesis (9). PA's in the human intestine can be produced by microbial species 121 belonging to the Clostridium subcluster XIVa, which are suppressed by AGO (12, 22) . 122
123
The current paper helps advance our understanding on beneficial physiological 124 effects of prebiotics on the host in regards to colon cancer. The authors provide data to 125
show that AGO, a prebiotic, suppresses HFD induced dysbiosis, change microbial 126 community function and prevent colonic tumorigenesis in a HFD mouse model. Future 127 studies investigating molecular mechanisms by which a prebiotic induces microbiota 128 changes exerting protective effects on the host will allow development of new microbiota 129 targeted therapies. 130
